Abstract

BackgroundConfusion between similar drug names is a common cause of potentially harmful medication errors. Interventions to prevent these errors at the point of prescribing have had limited success. The purpose of this study is to measure whether indication alerts at the time of computerized physician order entry (CPOE) can intercept drug name confusion errors.Methods and FindingsA retrospective observational study of alerts provided to prescribers in a public, tertiary hospital and ambulatory practice with medication orders placed using CPOE. Consecutive patients seen from April 2006 through February 2012 were eligible if a clinician received an indication alert during ordering. A total of 54,499 unique patients were included. The computerized decision support system prompted prescribers to enter indications when certain medications were ordered without a coded indication in the electronic problem list. Alerts required prescribers either to ignore them by clicking OK, to place a problem in the problem list, or to cancel the order. Main outcome was the proportion of indication alerts resulting in the interception of drug name confusion errors. Error interception was determined using an algorithm to identify instances in which an alert triggered, the initial medication order was not completed, and the same prescriber ordered a similar-sounding medication on the same patient within 5 minutes. Similarity was defined using standard text similarity measures. Two clinicians performed chart review of all cases to determine whether the first, non-completed medication order had a documented or non-documented, plausible indication for use. If either reviewer found a plausible indication, the case was not considered an error. We analyzed 127,458 alerts and identified 176 intercepted drug name confusion errors, an interception rate of 0.14±.01%.ConclusionsIndication alerts intercepted 1.4 drug name confusion errors per 1000 alerts. Institutions with CPOE should consider using indication prompts to intercept drug name confusion errors.

Highlights

  • Confusions between drug names that look and sound alike are a common, costly and persistent type of medication error [1,2,3]

  • As part of a separate project, we developed and implemented a set of clinical decision support (CDS) alerts to prompt prescribers to add problems to the electronic medical record (EMR) problem list when the prescriber ordered selected medications in the absence of a documented indication

  • We analyzed a total of 127,458 indication alerts

Read more

Summary

Introduction

Confusions between drug names that look and sound alike are a common, costly and persistent type of medication error (e.g., hydroxyzine/hydralazine, Fosamax/Flomax, Durasal/Durezol) [1,2,3]. Regulatory agencies and the pharmaceutical industry have taken steps to reduce the risk of these errors, [8,9] but few interventions have produced convincing evidence of sustained improvement in wrong drug error rates, especially at the point of prescribing. Developing additional effective methods to reduce the rate of drug name confusion errors is an important medication safety priority. Confusion between similar drug names is a common cause of potentially harmful medication errors. Interventions to prevent these errors at the point of prescribing have had limited success. The purpose of this study is to measure whether indication alerts at the time of computerized physician order entry (CPOE) can intercept drug name confusion errors

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call